BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garovic VD, Dechend R, Easterling T, Karumanchi SA, McMurtry Baird S, Magee LA, Rana S, Vermunt JV, August P. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension 2021;:HYP0000000000000208. [PMID: 34905954 DOI: 10.1161/HYP.0000000000000208] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Giorgione V, Jansen G, Kitt J, Ghossein-Doha C, Leeson P, Thilaganathan B. Peripartum and Long-Term Maternal Cardiovascular Health After Preeclampsia. Hypertension 2023;80:231-41. [PMID: 35904012 DOI: 10.1161/HYPERTENSIONAHA.122.18730] [Reference Citation Analysis]
2 Walton SL, Denton KM. Extracting Information From Sympathetic Nerve Traffic in Gestational Hypertension. Hypertension 2023;80:302-4. [PMID: 36652532 DOI: 10.1161/HYPERTENSIONAHA.122.20181] [Reference Citation Analysis]
3 Ishikawa T, Nishigori H, Akazawa M, Miyakoda K, Noda A, Ishikuro M, Metoki H, Iwama N, Saito M, Sugawara J, Kawame H, Yaegashi N, Kuriyama S, Mano N, Obara T. Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: A large claims database study 2010-2019. Pregnancy Hypertens 2023;31:73-83. [PMID: 36646019 DOI: 10.1016/j.preghy.2023.01.001] [Reference Citation Analysis]
4 Deng NJ, Xian-Yu CY, Han RZ, Huang CY, Ma YT, Li HJ, Gao TY, Liu X, Zhang C. Pharmaceutical administration for severe hypertension during pregnancy: Network meta-analysis. Front Pharmacol 2022;13:1092501. [PMID: 36699058 DOI: 10.3389/fphar.2022.1092501] [Reference Citation Analysis]
5 Lewey J. Challenges and opportunities to improving research in maternal cardiovascular health. Nat Cardiovasc Res 2023. [DOI: 10.1038/s44161-022-00201-x] [Reference Citation Analysis]
6 Hunley TE, Jones DP. Hypertension in the Pregnant Teenager. Pediatric Hypertension 2023. [DOI: 10.1007/978-3-031-06231-5_28] [Reference Citation Analysis]
7 Kim BS, Shin J. Post-Pregnancy Hypertension in Women With a History of Hypertensive Disorders of Pregnancy. Cardiometab Syndr J 2023;3. [DOI: 10.51789/cmsj.2023.3.e4] [Reference Citation Analysis]
8 Dasnoy-sumell G, Cordonnier C. Pathologies cérébrovasculaires et grossesse. Pratique Neurologique - FMC 2023. [DOI: 10.1016/j.praneu.2023.01.010] [Reference Citation Analysis]
9 Nurkkala J, Kauko A, Finngen, Laivuori H, Saarela T, Tyrmi JS, Vaura F, Cheng S, Bello NA, Aittokallio J, Niiranen T. Associations of polygenic risk scores for preeclampsia and blood pressure with hypertensive disorders of pregnancy. Journal of Hypertension 2022;Publish Ahead of Print. [DOI: 10.1097/hjh.0000000000003336] [Reference Citation Analysis]
10 Yi Yang, Yanxia Xie, Mingrong Li, Yi Mu, Peiran Chen, Zheng Liu, Yanping Wang, Qi Li, Xiaohong Li, Li Dai, Juan Liang, Jun Zhu. Characteristics and fetal outcomes of pregnant women with hypertensive disorders in China: a 9-year national hospital-based cohort study. BMC Pregnancy Childbirth 2022;22:924. [PMID: 36482386 DOI: 10.1186/s12884-022-05260-3] [Reference Citation Analysis]
11 Suhaimi D, Novri DA, Hamidy Y, Savira M. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia. F1000Res 2022;11:1287. [DOI: 10.12688/f1000research.125944.1] [Reference Citation Analysis]
12 Majmundar M, Doshi R, Patel KN, Zala H, Kumar A, Kalra A. Prevalence, Trends and Outcomes of Cardiovascular Diseases in Pregnant Patients in the United States: 2010 to 2019. Eur Heart J 2022:ehac669. [PMID: 36342471 DOI: 10.1093/eurheartj/ehac669] [Reference Citation Analysis]
13 Oliveira GMMD, Almeida MCCD, Marques-santos C, Costa MENC, Carvalho RCMD, Freire CMV, Magalhães LBNC, Hajjar LA, Rivera MAM, Castro MLD, Avila WS, Lucena AJGD, Brandão AA, Macedo AVS, Lantieri CJB, Polanczyk CA, Albuquerque CJDM, Born D, Falcheto EB, Bragança ÉOV, Braga FGM, Colombo FMC, Jatene IB, Costa IBSDS, Rivera IR, Scholz JR, Melo JXD, Santos MAD, Izar MCDO, Azevedo MF, Moura MS, Campos MDSB, Souza OFD, Medeiros OOD, Silva SCTFD, Rizk SI, Rodrigues TDCV, Salim TR, Lemke VDMG. Posicionamento sobre a Saúde Cardiovascular nas Mulheres – 2022. Arquivos Brasileiros de Cardiologia 2022;119:815-882. [DOI: 10.36660/abc.20220734] [Reference Citation Analysis]
14 Bortoletto P, Prabhu M, Baker VL. Association between programmed frozen embryo transfer and hypertensive disorders of pregnancy. Fertil Steril 2022;118:839-48. [PMID: 36171152 DOI: 10.1016/j.fertnstert.2022.07.025] [Reference Citation Analysis]
15 Ray JG, Austin PC, Park AL, Cohen E, Fang J, Chu A. Severity of obstructive coronary artery stenosis after pre-eclampsia. Heart 2022. [DOI: 10.1136/heartjnl-2022-321513] [Reference Citation Analysis]
16 Gong L, Liu M, Shi H, Huang Y. Uterine fibroids are associated with increased risk of pre-eclampsia: A case-control study. Front Cardiovasc Med 2022;9:1011311. [DOI: 10.3389/fcvm.2022.1011311] [Reference Citation Analysis]
17 Espeche WG, Salazar MR, Minetto J, Leiva Sisnieguez CE, Cerri G, Balbín E, Stavile RN, Carrera Ramos P, Soria A, Santillan C, Grassi F, Torres S, Carbajal HA. Hypertension arising after 20 weeks of gestation: gestational hypertension or masked chronic hypertension? J Hum Hypertens 2022. [PMID: 36224324 DOI: 10.1038/s41371-022-00767-w] [Reference Citation Analysis]
18 Thomopoulos C, Ilias I. Are pregnancy-associated hypertensive disorders so sweet? World J Clin Cases 2022; 10(28): 10384-10386 [DOI: 10.12998/wjcc.v10.i28.10384] [Reference Citation Analysis]
19 Giorgione V, Khalil A, O’driscoll J, Thilaganathan B. Peripartum Screening for Postpartum Hypertension in Women With Hypertensive Disorders of Pregnancy. Journal of the American College of Cardiology 2022;80:1465-1476. [DOI: 10.1016/j.jacc.2022.07.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wall HK, Streeter TE, Wright JS. An Opportunity to Better Address Hypertension in Women: Self-Measured Blood Pressure Monitoring. J Womens Health (Larchmt) 2022. [PMID: 36154466 DOI: 10.1089/jwh.2022.0371] [Reference Citation Analysis]
21 Sanga V, Rossitto G, Seccia TM, Rossi GP. Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review. Hypertension 2022;79:1912-21. [PMID: 35686552 DOI: 10.1161/HYPERTENSIONAHA.121.18858] [Reference Citation Analysis]
22 Federle L. Part II : Interactive case: Cardiovascular diseases in pregnancy. J Am Coll Clin Pharm 2022;5:1016-1020. [DOI: 10.1002/jac5.1689] [Reference Citation Analysis]
23 Niu Y, Zhao D, Wang Y, Suo L, Zou J, Wei D. Ovulation induction regimens are associated with a higher rate of livebirth after frozen single-blastocyst transfer among women with polycystic ovary syndrome. Front Endocrinol 2022;13:987813. [DOI: 10.3389/fendo.2022.987813] [Reference Citation Analysis]
24 Paula WO, Patriota ESO, Gonçalves VSS, Pizato N. Maternal Consumption of Ultra-Processed Foods-Rich Diet and Perinatal Outcomes: A Systematic Review and Meta-Analysis. Nutrients 2022;14:3242. [PMID: 35956418 DOI: 10.3390/nu14153242] [Reference Citation Analysis]
25 Cameron NA, Petito LC, Shah NS, Perak AM, Catov JM, Bello NA, Capewell S, O'Flaherty M, Lloyd-Jones DM, Greenland P, Grobman WA, Khan SS. Association of Birth Year of Pregnant Individuals With Trends in Hypertensive Disorders of Pregnancy in the United States, 1995-2019. JAMA Netw Open 2022;5:e2228093. [PMID: 36001318 DOI: 10.1001/jamanetworkopen.2022.28093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Giorgione V, Thilaganathan B. Reply. Ultrasound in Obstet & Gyne 2022;60:296-297. [DOI: 10.1002/uog.26026] [Reference Citation Analysis]
27 Ye W, Steenland K, Quinn A, Liao J, Balakrishnan K, Rosa G, Ndagijimana F, Ntivuguruzwa JD, Thompson LM, McCracken JP, Díaz-Artiga A, Rosenthal JP, Papageorghiou A, Davila-Roman VG, Pillarisetti A, Johnson M, Wang J, Nicolaou L, Checkley W, Peel JL, Clasen TF; Household Air Pollution Intervention Network (HAPIN) trial Investigators. Effects of a Liquefied Petroleum Gas Stove Intervention on Gestational Blood Pressure: Intention-to-Treat and Exposure-Response Findings From the HAPIN Trial. Hypertension 2022;79:1887-98. [PMID: 35708015 DOI: 10.1161/HYPERTENSIONAHA.122.19362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Lanthier L, Sauvé N, Plourde MÉ, Cauchon M. [In pregnant women with mild chronic hypertension, does a treatment strategy using a treatment target<140/90mmHg compared to watchful waiting unless BP>160/105mmHg reduce the incidence of maternal and perinatal complications while being safe?]. Rev Med Interne 2022;43:514-5. [PMID: 35868989 DOI: 10.1016/j.revmed.2022.07.003] [Reference Citation Analysis]
29 Rismiati H, Lee H. Blood pressure control in hypertensive disorders of pregnancy. CPP 2022;4:99-105. [DOI: 10.36011/cpp.2022.4.e16] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Bond RM, Phillips K, Ivy KN, Ogueri V, Parapid B, Miller SC, Ansong A. Cardiovascular Health of Black Women Before, During, and After Pregnancy: A Call to Action and Implications for Prevention. Curr Cardiovasc Risk Rep. [DOI: 10.1007/s12170-022-00703-0] [Reference Citation Analysis]
31 Rodriguez-carnero G, Lorenzo PM, Canton-blanco A, Mendizabal L, Arregi M, Zulueta M, Simon L, Macia-cortiñas M, Casanueva FF, Crujeiras AB. Genetic Variants in Folate and Cobalamin Metabolism-Related Genes in Pregnant Women of a Homogeneous Spanish Population: The Need for Revisiting the Current Vitamin Supplementation Strategies. Nutrients 2022;14:2702. [DOI: 10.3390/nu14132702] [Reference Citation Analysis]
32 Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson K, Haas DM, Plante L, Metz T, Casey B, Esplin S, Longo S, Hoffman M, Saade GR, Hoppe KK, Foroutan J, Tuuli M, Owens MY, Simhan HN, Frey H, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Kinzler W, Su E, Krishna I, Nguyen N, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Galis ZS, Harper L, Ambalavanan N, Geller NL, Oparil S, Cutter GR, Andrews WW; Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med 2022;386:1781-92. [PMID: 35363951 DOI: 10.1056/NEJMoa2201295] [Cited by in Crossref: 39] [Cited by in F6Publishing: 48] [Article Influence: 39.0] [Reference Citation Analysis]
33 Willy D, Willy K, Köster H, Braun J, Möllers M, Sourouni M, Klockenbusch W, Schmitz R, Oelmeier K. Blood Pressure Levels and Maternal Outcome in Women with Preeclampsia – a Retrospective Study from a Large Tertiary Obstetric Centre. Geburtshilfe Frauenheilkd 2022;82:528-34. [DOI: 10.1055/a-1783-7718] [Reference Citation Analysis]
34 Ford ND, Cox S, Ko JY, Ouyang L, Romero L, Colarusso T, Ferre CD, Kroelinger CD, Hayes DK, Barfield WD. Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization - United States, 2017-2019. MMWR Morb Mortal Wkly Rep 2022;71:585-91. [PMID: 35482575 DOI: 10.15585/mmwr.mm7117a1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Shimada N, Nakayama T, Umemura H, Kawana K, Yamamoto T, Uchigasaki S. A Case-Control Study of the APELA Gene and Hypertensive Disorders of Pregnancy. Medicina 2022;58:591. [DOI: 10.3390/medicina58050591] [Reference Citation Analysis]
36 Natterson-Horowitz B, Boddy AM, Zimmerman D. Female Health Across the Tree of Life: Insights at the Intersection of Women's Health, One Health and Planetary Health. PNAS Nexus 2022;1:pgac044. [PMID: 35668878 DOI: 10.1093/pnasnexus/pgac044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Mancia G, Kjeldsen SE, Kreutz R, Pathak A, Grassi G, Esler M. Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines. Hypertension 2022;79:1153-66. [PMID: 35378981 DOI: 10.1161/HYPERTENSIONAHA.122.19020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Chadha A, Tayade S. Urinary Protein-to-Creatinine Ratio: An Indicator of Adverse Clinical Outcomes in Preeclampsia With Proteinuria. Cureus. [DOI: 10.7759/cureus.23341] [Reference Citation Analysis]
39 Tlegenova Z. Management of hypertension in pregnancy. HVT 2022;6:8. [DOI: 10.24969/hvt.2022.303] [Reference Citation Analysis]
40 Oliveira GMMD, Wenger NK. Considerações Especiais na Prevenção de Doenças Cardiovasculares nas Mulheres. Arquivos Brasileiros de Cardiologia 2022;118:374-7. [DOI: 10.36660/abc.20220028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Hunley TE, Jones DP. Hypertension in the Pregnant Teenager. Pediatric Hypertension 2022. [DOI: 10.1007/978-3-319-31420-4_28-2] [Reference Citation Analysis]
42 Choi E, Kazzi B, Varma B, Ortengren AR, Minhas AS, Vaught AJ, Bennett WL, Lewey J, Michos ED. The Fourth Trimester: a Time for Enhancing Transitions in Cardiovascular Care. Curr Cardiovasc Risk Rep 2022;16:219-29. [PMID: 36159207 DOI: 10.1007/s12170-022-00706-x] [Reference Citation Analysis]
43 González-fernández D, Koski KG, Bhutta Z. Pregnancy: pre-eclampsia and diet. Reference Module in Food Science 2022. [DOI: 10.1016/b978-0-12-821848-8.00166-9] [Reference Citation Analysis]